Pharmaceutical Technology, Mar 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Mar 1, 2010
Featured Content
Trends in Bioprocessing
By Michelle Hoffman
The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
By Blake Anson , Emile Nuwaysir , Brad Swanson , Wen Bo Wang
The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes. This article is part of a special issue on Bioprocessing and Sterile Manufacturing.
A Detail View of Single-Use Equipment Opportunities
By Thomas Paust , Detelv Szarafinksi , Christian Manzke , Thorsten Peuker , Maik W. Jornitz
The authors propose increased use of single-use technologies in biopharmaceutical manufacturing to achieve operational excellence without compromising product quality.
Disposable Technologies for Fill-Finish of Clinical-Trial Materials
By Tony Pidgeon
The author examines the use and advantages of disposable technologies in the fill–finish of sterile pharmaceutical products and how these technologies can reduce costs and time in producing clinical-trial materials.
Cost Advantages of Single-Use Technologies
By Niels Guldager
Single-use technologies can help simplify equipment and facility design, thus bringing cost advantages. But how are these cost advantages realized and what criteria can be used to assess their impact? This article is part of a special issue on Bioprocessing and Sterile Manufacturing.
Integrated Microfluidic LC-MS
By Maggie Bynum , Tomasz Baginski , Kevin Killeen , Rodney Keck
The authors describe a new microfluidic-based workflow that integrates and automates glycan cleaveage, purification, and chromatographic separation onto a microfluidic liquid chromatography–mass spectrometry chip for MS detection.
Gamma Irradiation in the Pharmaceutical Manufacturing Environment
By Betty Howard
The author reviews the benefits, challenges, and considerations to be made when selecting a gamma-irradiation sterilization method.
The Myth Called "Sterility"
By James P. Agalloco , James E. Akers
The authors propose a process-centric approach for carrying out aseptic-processing and suggest further dialogue. This articles contains bonus online-exclusive material.
An Overview of Rapid Microbial-Detection Methods
By Erik Greb
Pharmaceutical Technology talked to drugmakers, equipment vendors, and service providers to learn more about the advantages and disadvantages of rapid microbial-detection methods.
Surface Plasmon Resonance as an Analytical Tool for Bioprocessing
By Michelle Hoffman
A Q&A with GE Healthcare

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here